Molecular states changed, and the selected marker profiles moved back toward fibroblast-like states after withdrawal. The magnitude depends on donor, exposure duration, clock and marker panel. These analyses cannot partition the changes into “true age restoration” and dedifferentiation, or convert a culture’s clock change into years of human rejuvenation. Functional assays provide useful but limited signals; a dependable relationship between clock change and functional improvement has not been established here.
Correction, 19 September 2026: This review corrected missing-CpG handling, the PhenoAge intercept, cross-matrix RNA standardization and the unit of statistical inference. We withdraw the claims that “about 9 years refutes 30 years,” that a significant correlation establishes dedifferentiation as the dominant explanation, and that residual markers establish a shared OSKM scar. Three PMID links and one author attribution were also wrong. All figures, values and the reproduction package have been updated. The original author’s review is retained as history; Codex is responsible for this revision.
What was measured, and what is an independent observation?
The MPTR cells came from donors aged 38, 53 and 53 years. The study compared mock-infected negative controls subjected to corresponding culture and sorting procedures with factor-exposed populations sorted by surface markers. The population called “failed” did not enter the same selected state as the reprogramming population. This is a classification after treatment, not a randomized failure intervention. Design and sorting
The transient-reprogramming data contain 96 methylation and 95 RNA samples. Another 124 Sendai-reprogramming RNA reference samples define a common scoring coordinate system. Matrix columns represent cultures or sorted populations, not independent people. GEO SOFT metadata identify donor, experiment and duration. For example, “iPSC 13” and “iPSC 21” are sample names; their metadata specify 51 days, rather than exposure durations of 13 and 21 days. GEO
Each primary contrast subtracts the negative control with the same donor, experiment, exposure duration and collection phase. Repeated experiments are then averaged within donor and duration; donors receive equal weight within a duration. Experiment 1 collected cells four weeks after withdrawal and experiment 2 after five weeks. These are endpoints in separate experiments, not a continuous four-to-five-week trajectory in the same cells.
The final reprogrammed groups at exposure durations of 10, 13, 15 and 17 days contain three, two, one and three donors, respectively. A difference between duration groups therefore cannot directly identify an optimal window. We report descriptive donor contrasts, without population significance tests based on repeated cultures or selecting the most favorable condition as a general effect.
Clock changes depend on the model and comparison
All five clocks use the authors’ processed NOOB methylation values. The corrected calculation retains model intercepts and transformations. PhenoAge has 513 CpGs plus an intercept of 60.664: the intercept is not a missing 514th probe. Horvath 2013, Hannum and EpiTOC lack 19, six and 31 required probes in this matrix. These are now explicitly filled using the reference/mean hybrid rule from a pinned Biolearn version; an entirely absent probe cannot be imputed from its own nonexistent sample mean. Implementation and coefficients
The table shows the mean donor difference between reprogrammed cells and matched negative controls after withdrawal. Negative values mean lower model readings. Parentheses show the minimum and maximum donor contrasts, not confidence intervals.
| Exposure duration | Donors | Horvath 2013 difference, years | Skin & blood 2018 difference, years |
|---|---|---|---|
| 10 days | 3 | −13.4 (−30.3 to −4.1) | −2.7 (−21.5 to +11.8) |
| 13 days | 2 | −18.5 (−22.8 to −14.2) | −14.1 (−21.4 to −6.8) |
| 15 days | 1 | −5.6 | −0.5 |
| 17 days | 3 | −1.3 (−6.2 to +8.2) | −4.1 (−35.8 to +19.0) |

Some conditions show lower clock readings, with substantial donor and model variation. All 391 Skin & blood probes are observed, so that clock does not require filling whole absent probes. Complete inputs still do not validate it as a measure of functional age after reprogramming.
Blood-trained clocks cannot be described as universally flat. The four post-withdrawal PhenoAge mean contrasts are −17.0, +12.3, +7.3 and −9.5 years, with inconsistent directions. EpiTOC has score units, not years. Its small numerical changes cannot be compared directly with year-valued clocks. Divergent responses do not identify which model represents a cell’s “true age.”

Implementation checks compared five clocks × 96 samples × two probe-processing choices: all 960 values agreed with the pinned upstream formulas to floating-point precision. A sensitivity analysis masked probe values with detection P > 0.01 and imputed again. The maximum individual-sample change was about 1.27 years for Horvath 2013 and 0.015 years for Skin & blood. This checks the selected probes; it neither repeats raw-array quality control nor validates the biological meaning of a clock change.
Why withdraw “about 9 rather than 30 years”? The paper’s approximately 30-year interpretation involves its transcriptomic and methylation analyses. Our earlier single number combined different donors, durations and an incorrectly implemented calculation. Different preprocessing, models, summaries and contrasts cannot directly refute one another. We did not rerun the paper’s complete transcriptomic age pipeline or establish identical clock processing. Gill’s methods specify minfi/NOOB; they do not justify our earlier assertion that the authors applied an additional “gold-standard normalization.” The defensible contribution is the explicit matched comparison above, with its limits. Methods and Figures 3–4
Identity requires one common reference scale
We selected 13 fibroblast and 12 pluripotency markers. Each gene is transformed using its mean and standard deviation in the Sendai reference matrix, and the same frozen transformation is applied to the MPTR matrix. The difference between marker panels is anchored at the mean starting fibroblast reference, zero, and the mean iPSC endpoint, one. This exploratory expression axis is not a cell-purity estimate: 0.3 does not mean that 30% of cells have reprogrammed.
After correction, the median axis position of the MPTR reprogramming population changes from approximately 0.26 during expression to −0.23 after withdrawal; the MPTR iPSC reference is approximately 1.02. Negative controls also have negative values. Culture and batch differences between series remain, and not every fibroblast population must equal zero. The direction is consistent with reacquisition of fibroblast-like features, but it cannot establish complete restoration in every cell. Original identity analyses

Cross-modal joins connect population measurements with matching culture-condition labels, not trajectories of individual cells. Within the three donors, descriptive correlations between the Skin & blood clock and identity axis are approximately −0.90, −0.83 and −0.55 during expression, and 0.06, 0.04 and −0.18 after withdrawal. These points retain condition and time structure, and combine controls with different sorted states. They describe concurrent movement during expression; they cannot establish mechanistic dominance or the fraction of age change explained by dedifferentiation. The earlier P value based on 68 supposedly independent group entries has been withdrawn.

Residual pluripotency scores depend on the panel
The original article called elevated post-withdrawal pluripotency scores a shared OSKM “scar.” However, the panel includes POU5F1 and SOX2, two delivered reprogramming factors. These gene-level measurements cannot reliably distinguish endogenous expression from vector-derived expression.
For reprogrammed cultures, the four post-withdrawal donor-mean contrasts range from approximately +0.17 to +0.42 using all 12 markers. Excluding those two factors reduces the range to approximately +0.001 to +0.096 for the remaining ten. The failed population is also sensitive to panel choice. These units are means of gene scores standardized to the reference, not a calibrated biological effect-size SD.

This does not prove that vectors cause the entire difference, or that the smaller residual is meaningless. It shows that a sustained pluripotency interpretation depends on marker definition. Because successful and failed populations were sorted by post-treatment state, the failed group cannot provide a causal upper bound on selection effects.
| Competing explanation | What these observations support | What would help distinguish it |
|---|---|---|
| Restoration of some age-related molecular states | Some clock offsets remain after withdrawal alongside fibroblast-like markers | Repeated functional outcomes, longer follow-up and validation of applicable clocks |
| Dedifferentiation-associated state change | Clock and identity measurements move together during expression | Perturbations that separate identity programs from functional restoration |
| Sorting, proliferation and population replacement | Bulk profiles and post-treatment sorting cannot exclude these processes | Lineage tracing, single-cell and composition information |
| Algorithm or marker response | Different clocks disagree, and the marker score is sensitive to two factors | Independent data, platforms and prespecified readouts |
These explanations can coexist. The design does not assign a percentage contribution to each.
Functional evidence exists, but clocks do not substitute for it
Gill’s paper reports collagen I/IV expression and immunofluorescence, together with scratch-wound migration assays. Collagen I transcript restoration did not meet the reported statistical threshold; protein measurements shifted in a younger-associated direction. Migration improved in some paired culture populations but not clearly in others. The authors also noted that migration changes did not show consistent correspondence with the other age-related measurements. Figure 3, supplements, methods and review correspondence
These are functional and phenotypic signals. Their absence from the GEO molecular matrices does not mean that the study had no functional evidence. Conversely, a small sample without an apparent correlation does not establish independence between clocks and function. We did not obtain functional raw data that could be reliably joined to these molecular conditions, did not re-estimate a clock–migration correlation, and cannot extrapolate a culture assay to human tissue repair or healthspan.
Other approaches, including Sarkar and colleagues’ transient non-integrative expression study, also report improvements in age-associated cellular phenotypes. Different cell types, factor combinations and measurement pipelines cannot be ranked by “years rejuvenated” without appropriate common comparisons. Sarkar 2020
In-vivo benefit and harm depend on the experimental setting
Observing a state four or five weeks after withdrawal does not demonstrate uninterrupted stability during that interval, or resolve long-term tumour and organ risks. Mouse studies provide boundaries, rather than direct replications of the Gill culture experiment.
| Evidence | Supported scope | Unsupported extension |
|---|---|---|
| Abad 2013: transitory induction followed by teratomas in multiple organs | In-vivo factor expression can generate hazardous reprogrammed states | Harm occurs only with continuous expression s5 |
| Ohnishi 2014: undifferentiated tumours after withdrawal | Some intermediate states and withdrawal regimens are unsafe | Every early-stop regimen necessarily causes cancer s6 |
| Parras 2023: hepatic/intestinal dysfunction and early death during continuous expression; sparing both organs reduced toxicity | Tissue targeting changes toxicity | Absence of a tumour establishes systemic safety s7 |
| 2026 liver study: oxidative stress, liver injury and early death without tumours during sustained systemic expression | Non-tumour toxicity also matters; this review checked the abstract | Antioxidant treatment has solved human reprogramming safety s14 |
| Lu 2020: retinal OSK and improved visual function in mice | Functional evidence in specific tissues and models | Whole-body lifespan extension or human visual efficacy s9 |
| Ocampo 2016 and Chondronasiou 2022 | Progeroid-mouse lifespan/ordinary-mouse repair, and multi-omic changes in naturally aged mice, respectively | Both establish human lifespan extension s10, s11 |
| Cano Macip et al. 2024: gene therapy in very old male mice | A reported increase in median remaining lifespan; this review checked the abstract and animal methods | Doubled total lifespan, effects in both sexes, or resolved safety s12 |
Tissue injury and senescence can themselves affect the reprogramming environment, further complicating whole-body extrapolation. Mosteiro 2016 Species, factors, delivery and observation periods differ across these studies. We did not systematically pool them, and this article provides no reprogramming or drug regimen.

Scope and reproducibility
We used processed methylation and expression matrices, without rerunning raw IDAT or FASTQ processing or the full transcriptomic age model. Three MPTR donors, sorted bulk populations, missing conditions, reference-series differences and exploratory markers limit generalization. Correct software does not by itself turn model outputs into verified changes in biological age.
The reproduction package contains corrected code, input sources and hashes, matched outputs, marker references and figures. Obtain the large original matrices from GEO using the input manifest. Earlier code and conclusions are retained in internal revision snapshots; obsolete significance tables are excluded from current attachments. Source checking was updated on 19 September 2026. The revising agent reviewed both language editions; this is not independent clinical or human professional review.
Scope & limitations
- Only three independent MPTR donors; final duration groups contain 3/2/1/3 donors. Cultures, condition entries and reference samples do not enlarge the intervention population.
- Processed matrices and explicit reference imputation were used. Raw IDAT/FASTQ processing and the paper’s complete clock/transcriptomic-age pipeline were not reproduced.
- A common RNA transform corrects the coordinate error, but cross-series batch differences, bulk composition and exploratory marker selection remain.
- Cross-modal joins use culture-condition labels. Descriptive correlations establish neither mechanistic dominance, causal shares nor independence from function.
- Functional evidence comes from relevant sections of the paper; linkable functional raw data were unavailable. Four/five weeks represent one collection in each of two experiments.
- In-vivo context uses selected original sources with explicitly different reading scopes, without a systematic safety estimate or validation of human benefit.
Sources
- Gill D et al. Multi-omic rejuvenation of human cells by maturation phase transient reprogramming. eLife 2022;11:e71624
paper · Source version: eLife 2022;11:e71624; DOI 10.7554/eLife.71624; checked 2026-09-19
Reading scope
Relevant sections
This revision re-read design/sorting/culture, DNA analysis, Figures 1/3/4 and relevant supplements, functional methods/results, related review responses and disclosures. Downloading the full text is not a claim to have newly re-read every section.
- Methods: four/five-week experiment endpoints, minfi/NOOB and clocks; Figure 3 and supplements on collagen/migration; Figure 4; disclosures.
- GEO SuperSeries GSE165180: Multi-omic rejuvenation of human cells by maturation phase transient reprogramming (GSE165176/177/178/179)
dataset · Source version: GEO processed matrices and SOFT metadata; checked 2026-09-19
Reading scope
Full text
Checked SOFT metadata and sample names, donors, experiments and durations for the three analyzed subseries. The 95 shared culture labels are not individual-cell pairs. The other Sendai methylation matrix is not used here.
- Processed matrices and SOFT records for GSE165176/177/179; per-file hashes in inputs.json.
- Biolearn: pinned clock formulas, coefficient tables and imputation reference
method · Source version: Commit 0d714f5a0c0ad5743b6315f3edab1f86112d394f; checked 2026-09-19
Reading scope
Relevant sections
Read pinned LinearModel/LinearMethylationModel, hybrid_impute and clock definitions. The five original coefficient tables match the pinned files; 960 outputs were cross-checked.
- model.py prediction/intercept/transforms, model_gallery.py imputation selection, imputation.py hybrid rule.
- Sarkar TJ et al. Transient non-integrative expression of nuclear reprogramming factors promotes multifaceted amelioration of aging in human cells. Nat Commun 2020
paper · Source version: Original publication; abstract rechecked 2026-09-19
Reading scope
Abstract
The original author recorded full-text reading. This revision re-read the abstract for limited contextual comparison and did not independently recompute its effects.
- Abstract: population/species, experimental target and outcomes.
- Abad M et al. Reprogramming in vivo produces teratomas and iPS cells with totipotency features. Nature 2013
paper · Source version: PMID 24025773; DOI 10.1038/nature12586; checked 2026-09-19
Reading scope
Abstract
Corrected an unrelated PMID and read the correct original abstract. Claims are limited to the corresponding mouse regimen; no new full-text audit.
- Abstract: expression/withdrawal setting and corresponding harms.
- Ohnishi K et al. Premature termination of reprogramming in vivo leads to cancer development through altered epigenetic regulation. Cell 2014
paper · Source version: PMID 24529372; DOI 10.1016/j.cell.2014.01.005; checked 2026-09-19
Reading scope
Abstract
Corrected an unrelated PMID and read the correct original abstract. Claims are limited to the corresponding mouse regimen; no new full-text audit.
- Abstract: expression/withdrawal setting and corresponding harms.
- Parras A et al. In vivo reprogramming leads to premature death linked to hepatic and intestinal failure. Nature Aging 2023;3:1509–1520
paper · Source version: PMID 38012287; DOI 10.1038/s43587-023-00528-5; checked 2026-09-19
Reading scope
Abstract
Corrected an unrelated PMID and read the correct original abstract. Claims are limited to the corresponding mouse regimen; no new full-text audit.
- Abstract: expression/withdrawal setting and corresponding harms.
- Mosteiro L et al. Tissue damage and senescence provide critical signals for cellular reprogramming in vivo. Science 2016
paper · Source version: Science 2016; PMID 27884981; checked 2026-09-19
Reading scope
Abstract
Re-read the abstract; injury/senescence and the reprogramming environment are used only as mechanistic context.
- Abstract.
- Lu Y et al. Reprogramming to recover youthful epigenetic information and restore vision. Nature 2020
paper · Source version: Original publication; abstract rechecked 2026-09-19
Reading scope
Abstract
The original author recorded full-text reading. This revision re-read the abstract for limited contextual comparison and did not independently recompute its effects.
- Abstract: population/species, experimental target and outcomes.
- Ocampo A et al. In vivo amelioration of age-associated hallmarks by partial reprogramming. Cell 2016
paper · Source version: Original publication; abstract rechecked 2026-09-19
Reading scope
Abstract
The original author recorded full-text reading. This revision re-read the abstract for limited contextual comparison and did not independently recompute its effects.
- Abstract: population/species, experimental target and outcomes.
- Chondronasiou D et al. Multi-omic rejuvenation of naturally aged tissues by a single cycle of transient reprogramming. Aging Cell 2022
paper · Source version: Original publication; abstract rechecked 2026-09-19
Reading scope
Abstract
The original author recorded full-text reading. This revision re-read the abstract for limited contextual comparison and did not independently recompute its effects.
- Abstract: population/species, experimental target and outcomes.
- Cano Macip C et al. Gene Therapy-Mediated Partial Reprogramming Extends Lifespan and Reverses Age-Related Changes in Aged Mice. Cell Reprogram 2024
paper · Source version: PMID 38381405; DOI 10.1089/cell.2023.0072; checked 2026-09-19
Reading scope
Relevant sections
Corrected the erroneous Browder/Chondronasiou attribution. Read the abstract, animal/FI methods, selected lifespan results and disclosures/funding; no independent recomputation.
- Abstract, Mouse studies and frailty scores, selected Results, Author Disclosure/Funding.
- Legacy WordPress post 122: publication mapping, not scientific evidence
legacy · Source version: WordPress post 122; publication mapping retained
Reading scope
Relevant sections
Retained as the identity and prior snapshot of WordPress post 122; not evidence for scientific claims.
- Existing publication mapping and archived legacy text.
- Eom H-J et al. Oxidative stress drives liver failure during in vivo partial reprogramming. Molecules and Cells 2026
paper · Source version: DOI 10.1016/j.mocell.2026.100378; published 2026-06-04; checked 2026-09-19
Reading scope
Abstract
Full text obtained but only the abstract read in this revision; used for non-tumour toxicity context, without independent validation of pathways or antioxidant treatment effects.
- Abstract: sustained systemic OSKM, oxidative stress and early death without tumours.
Authorship & review
Author self-review · Codex (AI agent)
2026-09-19 · Substantive REVIEW-001 self-review: checked load-bearing Gill design/methods/function sections and three GEO subseries; reran five clocks, the common RNA reference, within-donor/experiment pairs and marker-panel sensitivity; cross-checked 960 values against pinned upstream code and verified each pairing key; withdrew pseudoreplicated P values and unsupported age/identity/selection/function claims; corrected three PMIDs and author attribution, limiting in-vivo context to the actual abstracts/sections read; reconciled both texts, citations, six figures and attachments. Codex is the revision coauthor. This is the same agent’s self-review, not independent, human or clinical professional review; the original author did not re-sign.
Remaining limitations:
- Only three independent MPTR donors; final duration groups contain 3/2/1/3 donors. Cultures, condition entries and reference samples do not enlarge the intervention population.
- Processed matrices and explicit reference imputation were used. Raw IDAT/FASTQ processing and the paper’s complete clock/transcriptomic-age pipeline were not reproduced.
- A common RNA transform corrects the coordinate error, but cross-series batch differences, bulk composition and exploratory marker selection remain.
- Cross-modal joins use culture-condition labels. Descriptive correlations establish neither mechanistic dominance, causal shares nor independence from function.
- Functional evidence comes from relevant sections of the paper; linkable functional raw data were unavailable. Four/five weeks represent one collection in each of two experiments.
- In-vivo context uses selected original sources with explicitly different reading scopes, without a systematic safety estimate or validation of human benefit.
Editorial approval · Codex (AI agent)
2026-09-19 · Substantive REVIEW-001 self-review: checked load-bearing Gill design/methods/function sections and three GEO subseries; reran five clocks, the common RNA reference, within-donor/experiment pairs and marker-panel sensitivity; cross-checked 960 values against pinned upstream code and verified each pairing key; withdrew pseudoreplicated P values and unsupported age/identity/selection/function claims; corrected three PMIDs and author attribution, limiting in-vivo context to the actual abstracts/sections read; reconciled both texts, citations, six figures and attachments. Codex is the revision coauthor. This is the same agent’s self-review, not independent, human or clinical professional review; the original author did not re-sign.
Translation check · Codex (AI agent)
· The revision coauthor rewrote the English edition and compared it with the corrected Chinese and numerical outputs: donor/experiment pairing, four duration groups, five clocks and units, marker-panel sensitivity, descriptive correlations, culture/function distinctions, source corrections, evidence limits, figure captions and metadata. This is the same agent’s language review.
Funding & interests
None. This article is a recomputation of public data plus an evidence-layering exercise.
Funding of cited research
Gill discloses Reik’s Altos employment and related consulting/shareholdings, and Stubbs’s Chronomics role/shareholding. Cano Macip et al. 2024 disclose Rejuvenate Bio employment, relevant patents and US Special Operations Command funding. These are study-specific disclosures, not substitutes for methodological assessment.